Home
Home

Plexxikon

Roche's vemurafenib plays a starring role at ASCO

Roche's vemurafenib plays a starring role at ASCO
Fierce Biotech

Roche cancer programs angle for a starring role at ASCO

Roche cancer programs angle for a starring role at ASCO
Fierce Biotech

10 promising late-stage cancer drugs

10 promising late-stage cancer drugs
Fierce Biotech

News

Daiichi Sankyo, Kyowa Hakko Signal More Japanese Drug Takeovers
Bloomberg

News

Daiichi Sankyo nabs tiny Plexxikon in $935M deal
Fierce Biotech

News

Roche Scores Big With Plexxikon and Immunogen Deals
Seeking Alpha

News

Four Big Areas to Watch at the Upcoming ASCO Meeting, Biotech's Biggest Cancer Confab
BNET Pharma
»

News

Plexxikon Treats Initial Patient with First-in-Class Drug in Phase 1 Trial
Pipeline Review
»